An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
10 transgender people share the ‘strength and joy’ of their lives after transition
Transgender people overwhelmingly describe their l
A Test Told Me I’m Basically Made of Plastic. You Probably Are Too
I might like to think of my body as a thing
Whooping Cough Is Surging in China With Tens of Thousands of Cases and Over a Dozen Deaths
Whooping cough is making a post-pandemic co